 ?您的位置：對照品 > 標(biāo)準(zhǔn)品 > 歐洲藥典標(biāo)準(zhǔn)品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：S141652 |
| 產(chǎn)品名稱：Saroglitazar-d5 |
| 產(chǎn)品CAS： |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
S141652 |
| 名稱: |
Saroglitazar-d5 |
| 別名: |
Lipaglyn-d5; (αS)-α-Ethoxy-4-[2-[2-methyl-5-[4-(methylthio)phenyl]-1H-pyrrol-1-yl]ethoxy]benzenepropanoic Acid-d5 |
| 參考CAS號: |
495399-09-2 |
| 分子式: |
C??H??D?NO?S |
| 分子量: |
444.6 |
| 類別: |
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Saroglitazar-d5 is a deuterated version of Saroglitazar (S141650), an antidiabetic drug and a novel PPARα/y agonist. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
